Monday, April 08, 2013
Anacor Pharmaceuticals Receives Significant Investment to Support Neglected Disease Research
PALO ALTO, Calif.--(BUSINESS WIRE)-- Anacor Pharmaceuticals (NASDAQ:ANAC) today announced that it has signed a research agreement with the Bill & Melinda Gates Foundation (the Gates Foundation) to discover drug candidates intended to treat two filarial worm diseases (onch...
READ MORE
Friday, March 15, 2013
Call for BWF Schistosome Toolbox Travel Award Applications
We are pleased to announce that the Burroughs Wellcome Fund has generously agreed to fund a fourth round of travel awards to graduate students and postdoctoral scholars to foster new collaborations and transfer technology in the schistosome research community.
A selectio...
READ MORE
Friday, October 19, 2012
CDIPD parasitologist a finalist for 2012 Deloitte QB3 Innovation Award
CDIPD parasitologist Anjan Debnath was one of the five finalists for 2012 Deloitte QB3 Award for Innovation, which is given to a student, postdoc, or staff scientist (or their team), whose research is judged to have the greatest capacity to advance human health.
The Cent...
READ MORE
Thursday, August 16, 2012
Parasitic Helminths: Targets, Screens, Drugs and Vaccines
Parasitic Helminths:
Targets, Screens, Drugs and Vaccines. Drug Discovery in Infectious Diseases.
Volume editor: Conor R. Caffrey.
The book showcases the state-of-the-art in the fields of drug- and vaccine-development for parasitic helminths (worms) of consequence to h...
READ MORE
Featured Stories
After a week full of swimming, fishing, boating, camping, and wonderful fami...
Auranofin, an approved drug for the treatment of rheumatoid arthritis, could ser...
A cheap drug, which is already prescribed for arthritis, could fight amoebic dys...
A drug candidate that is nearing clinical trials against a Latin American parasi...
Press Releases
Directions
UCSF Mission Bay Campus
Byers Hall, 5th Floor, Suite 5081700 4th Street, San Francisco





















